SuperworthMineralys Therapeutics market cap MLYS
Share price times shares outstanding: what the whole company sells for, since 2023.
- Today, Oct 23, 2026
- $1.8B
- Highest close in our data
- $3.4B
- Nov 2025
Mineralys Therapeutics is worth $1.8B at the close on Oct 23, 2026, at $20.55 a share.
That is down 31% over the last year.
Its highest close in our data was $3.4B in Nov 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.8B | $1.8B | $2.8B | −38% |
| 2025 | $2.9B | $455.5M | $3.4B | +361% |
| 2024 | $638M | $355.6M | $718.9M | +80% |
| 2023 | $353.5M | $257.7M | $696.6M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Mineralys Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| MLYSMineralys Therapeutics | $1.8B |
| ANIPANI Pharmaceuticals | $1.7B |
| PAHCPhibro Animal Health | $1.6B |
| HRMYHarmony Biosciences | $2.1B |
| PBHPrestige Consumer Healthcare | $2.3B |
| ANABAnaptysbio | $1.5B |
| PCRXPacira BioSciences | $1.5B |
| OMEROmeros | $1.2B |
| NRIXNurix Therapeutics | $2.8B |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OGNOrganon | $3.6B |
| Peer median | $1.6B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Mineralys Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.